Altshuler Shaham LTD Xenon Pharmaceuticals Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $291,044 - $384,308	-11,600 Reduced 21.64%	42,000 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $796,496 - $1.04 Million	53,600 New	53,600 $823,000
Q4 2020 Feb 16, 2021	SELL	$9.49 - $16.04 $1.44 Million - $2.43 Million	-151,235 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$8.08 - $17.57 $234 - $509	29 Added 0.02%	151,235 $1.72 Million
Q3 2019 Nov 12, 2019	BUY	$8.74 - $10.51 $12,655 - $15,218	1,448 Added 0.97%	151,206 $1.35 Million
Q2 2019 Aug 06, 2019	BUY	$8.51 - $10.75 $52,345 - $66,123	6,151 Added 4.28%	149,758 $1.48 Million
Q1 2019 May 15, 2019	BUY	$6.39 - $10.42 $291,384 - $475,152	45,600 Added 46.53%	143,607 $1.46 Million
Q4 2018 Feb 11, 2019	BUY	$5.61 - $12.62 $549,819 - $1.24 Million	98,007 New	98,007 $618,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.